Keyphrases
Infliximab
100%
Acute Severe Ulcerative Colitis
100%
Severe Disease
16%
Prednisone
16%
Serum Concentration
16%
Abdominal Pain
16%
Bacterial Infection
16%
Cytomegalovirus
16%
Clinical Response
16%
Young Female
16%
Hospitalization
16%
Second Dose
16%
Weight-based
16%
Ulcerative Colitis
16%
Viral Infection
16%
Concentration Level
16%
Corticosteroids
16%
Early Recognition
16%
Clinical Remission
16%
Stool Frequency
16%
Colectomy Rate
16%
Induction Regimen
16%
Mesalazine Enema
16%
Induction Therapy
16%
Accelerated Induction
16%
Hydrocortisone
16%
Inappropriate Treatment
16%
Clostridioides Difficile
16%
Potentially Life-threatening Conditions
16%
Hematochezia
16%
Days of Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
100%
Infliximab
100%
Disease
16%
Abdominal Pain
16%
Prednisone
16%
Virus Infection
16%
Cytomegalovirus
16%
Remission
16%
Hydrocortisone
16%
Bacterial Infection
16%
Peptoclostridium difficile
16%
Rectum Hemorrhage
16%
Azathioprine
16%
Aminosalicylic Acid
16%
Enema
16%
Medicine and Dentistry
Ulcerative Colitis
100%
Infliximab
100%
Disease
16%
Prednisone
16%
Azathioprine
16%
Abdominal Pain
16%
Cytomegalovirus
16%
Virus Infection
16%
Bacterial Infection
16%
Peptoclostridium difficile
16%
Mesalazine
16%
Hydrocortisone
16%
Rectal Bleeding
16%
Colectomy
16%
Enema
16%
Immunology and Microbiology
Infliximab
100%
Ulcerative Colitis
100%
Prednisone
16%
Cytomegalovirus
16%
Blood Level
16%
Viral Disease
16%
Peptoclostridium difficile
16%
Azathioprine
16%
Cortisol
16%